Navigation Links
ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2011
Date:1/26/2012

SAN DIEGO, Jan. 26, 2012 /PRNewswire/ --ResMed Inc. (NYSE: RMD) today announced record revenue and income for the quarter ended December 31, 2011.  Revenue for the quarter ended December 31, 2011 was $332.7 million, a 9% increase (also a 9% increase on a constant currency basis) over the quarter ended December 31, 2010.  For the quarter ended December 31, 2011, net income was $62.9 million, an increase of 8%, compared to the quarter ended December 31, 2010.  Diluted earnings per share for the quarter ended December 31, 2011 were $0.42, an increase of 14% compared to the quarter ended December 31, 2010.  

(Logo:  http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

SG&A expenses were $100.6 million for the quarter ended December 31, 2011, an increase of $9.0 million, or 10% (a 9% increase on a constant currency basis) over the quarter ended December 31, 2010.  The increase in SG&A was primarily due to expenses necessary to support sales growth.  SG&A costs were 30% of revenue in the quarter ended December 31, 2011, compared to 30% in the quarter ended December 31, 2010.R&D expenses were $27.2 million for the quarter ended December 31, 2011, or 8% of revenue.  R&D expenses increased by 24% (a 21% increase on a constant currency basis) compared to the quarter ended December 31, 2010.  

The company amortized acquired intangibles of $3.7 million ($2.7 million, net of tax) during the quarter ended December 31, 2011.  Stock-based compensation costs incurred during the quarter ended December 31, 2011 of $7.4 million ($5.8 million, net of tax) consisted of expenses associated with stock options, restricted stock units, and our employee stock purchase plan.  

For the six months ended December 31, 2011, revenue was $647.5 m
'/>"/>

SOURCE ResMed Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ResMed Announces Change to Outside US Dial-in Number for Conference Call and Webcast to Discuss Second Quarter 2012 Results
2. ResMed Announces Conference Call and Webcast to Discuss Second Quarter 2012 Results
3. ResMed Inc. Announces Financial Results for the Quarter Ended September 30, 2011
4. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2012 Results
5. ResMed Inc. to Present at Upcoming Conferences
6. CareFusion and ResMed Announce Distribution Agreement for U.S. Hospital Market
7. ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2011 Results
8. ResMed Announces Acquisition of BiancaMed
9. ResMed Announces New iPhone App
10. ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011
11. The Next Generation in Bilevel Therapy Now Available on ResMeds Award-Winning S9™ Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Pa. , Sept. 2, 2015 ... increases, diversifies revenue base with highly profitable specialty ... , Near-term growth potential with 11 product ... include Paragraph IV certifications  , Provides medium ... candidates in development, including eight controlled substances ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ) has announced ... UK - November 19-20, 2015)" conference to their ... cover industry case studies, regulatory updates, latest therapies and ... Steven Nichols , OINP Specialist Consultant and ... Companies participating include: - Aptar Pharma ...
(Date:9/2/2015)... 2, 2015  Seeger Weiss LLP is reporting that ... commence October 13, 2015. Since the ... approval program, Zimmer NexGen knee implant surpassed FDA investigation ... companies provide evidence that the product is substantially similar ... gain permissions. In 2001, Zimmer began ...
Breaking Medicine Technology:Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 3Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 4Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 5Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 6Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
(Date:9/3/2015)... ... ... Mum n Me is pleased to announce the launch of its ... maximum protection from sun exposure, wind, bugs, and germs. The Mum n Me Baby ... keeping the cover securely in place. The new car seat cover is made with ...
(Date:9/3/2015)... ... September 03, 2015 , ... At Renew Man™, we have seen an increasing ... care model, where the primary care physician dictates and the patient obeys. Instead, our ... about their health issues and empowered to choose their own treatment options. , Recognizing ...
(Date:9/3/2015)... Kingston, NY (PRWEB) , ... September 03, 2015 , ... ... on iTunes, April Hannah & Michael Habernig from Path 11 Productions have had great ... This new age podcast has featured Hay House authors, Teal Swan who is the ...
(Date:9/3/2015)... ... September 03, 2015 , ... Doctor Kayode Sotonwa ... health professionals out there. His perspective on internal medicine keeps patients happy and healthy, ... healthy is important regardless of the season, but even more so in the fall, ...
(Date:9/2/2015)... ... September 03, 2015 , ... The Aspen Clinic (TAC), ... retreats geared towards kick-starting and inspiring wellness in the Roaring Fork Valley and beyond. ... developing a whole mind-body approach to fitness - we are much more than a ...
Breaking Medicine News(10 mins):Health News:Mum n Me Announces New Baby Car Seat Cover 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:TAC Introduces New Retreats for Fall Fitness 2
... An international team of cancer specialists and imaging ... response to treatment//. The guidelines will provide clinicians ... clinical trials of lymphoma treatments and should facilitate ... guidelines developed by the International Harmonization Project (IHP) ...
... born to mothers who smoked during pregnancy may find ... study//. ,A recent animal research suggests that ... find it difficult to quit smoking. Duke University Medical ... to nicotine is known to alter areas of the ...
... insurance to around 1.2 million families below the poverty ... ,"We are aware of the health challenges and ... decided to provide health insurance to BPL families, and ... project this year," Kumaraswamy said in Ingalagi village in ...
... suffering from asthma compared to other methods of ... of different medicines. ,Although several ... clinical trials directly comparing them have not been ... ,For the first time, researchers in the Childhood ...
... Some obese have not looked up from their plate full of ... for the free obesity surgery.// ,Earlier, the government ... medical condition could get the obesity surgery done, free of cost. ... avail the free surgery offered by the government. ,People ...
... stress and depression,// may be associated with higher ... in turn are related to an increased risk for ... 22 issue of Archives of Internal Medicine, one of ... studies have linked psychosocial characteristics with cardiovascular disease and ...
Cached Medicine News:Health News:New Guidelines For Assessing Lymphoma Treatment 2Health News:New Guidelines For Assessing Lymphoma Treatment 3Health News:Quitting Not Easy for Smokers Born to Smoking Women 2Health News:Karnataka's Free Health Insurance to the Poor 2Health News:Psychosocial Factors Associated With Higher Levels of Inflammatory Markers 2
... With the increase in Endoscopic cases it is ... Monitor with the Surgical Light. This combination ... without having to adopt an uncomfortable pose. ... including the NUVO Monitoring System. As such ...
... This configuration offers all the performance of a ... perfectly for use in Outpatient Settings, Minor Procedure ... Mounting two single lights either side of the ... in a General OR when combining Flat Screen ...
A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....
Triturus® is an open and completely automated ELISA immunoassay analyzer which can perform a variety of different tests on a series of samples and process several batches simultaneously....
Medicine Products: